Cerus reported $-13.51M in EBITDA for its fiscal quarter ending in March of 2023.





Ebitda Change Date
GRIFOLS EUR 347.45M 210K Dec/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Neogen USD 48.2M 546K Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Quidel USD 153.3M 23.8M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Terumo JPY 69.99B 3.22B Dec/2025